Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 May 15;10:2561–2567. doi: 10.2147/OTT.S137491

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2017 Du et al. This work is published and licensed by Dove Medical Press Limited

The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.

PMC Copyright notice

Flow cytometric results of various immunocompetent cells in PCa patients and healthy volunteers.

Notes: Phenotypic studies were performed by flow cytometric analysis using fluorescence-conjugated antihuman antibodies double-staining CD3 FITC/CD4 PE, CD3 FITC/CD8 PE, CD3 FITC/CD19 PE, CD3 FITC/CD16/CD56 PE. The data were expressed in a box-plot format by GraphPad Prism 5. Various immunocompetent cells including CD3+ T (A), CD4+ T (B), CD8+ T (C), and CD3-CD16+/CD56+ (E) were dysregulated in PCa patients, and the ratio of CD4/CD8 (D) was also significantly reduced in the patient population. However, there was no significant difference between the two groups in CD19+ B cells (F).

Abbreviation: PCa, prostate cancer.